| __timestamp | Dr. Reddy's Laboratories Limited | Gilead Sciences, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12402000000 | 2854000000 |
| Thursday, January 1, 2015 | 17449000000 | 3014000000 |
| Friday, January 1, 2016 | 17834000000 | 5098000000 |
| Sunday, January 1, 2017 | 19551000000 | 3734000000 |
| Monday, January 1, 2018 | 18265000000 | 5018000000 |
| Tuesday, January 1, 2019 | 15607000000 | 9106000000 |
| Wednesday, January 1, 2020 | 15410000000 | 5039000000 |
| Friday, January 1, 2021 | 16541000000 | 5363000000 |
| Saturday, January 1, 2022 | 17482000000 | 4977000000 |
| Sunday, January 1, 2023 | 19381000000 | 6923000000 |
| Monday, January 1, 2024 | 22873000000 | 5907000000 |
Cracking the code
In the competitive world of pharmaceuticals, research and development (R&D) spending is a key indicator of innovation and future growth. Over the past decade, Gilead Sciences, Inc. and Dr. Reddy's Laboratories Limited have showcased contrasting strategies in their R&D investments. From 2014 to 2023, Dr. Reddy's Laboratories consistently outpaced Gilead, with R&D expenses peaking at an impressive 22.9 billion in 2024. This represents a growth of approximately 84% from their 2014 spending. In contrast, Gilead's R&D expenditure saw a more modest increase, with a notable peak in 2019 at 9.1 billion, before stabilizing around 6.9 billion in 2023. The data suggests that while Dr. Reddy's is aggressively investing in innovation, Gilead is taking a more measured approach. Missing data for Gilead in 2024 leaves room for speculation on their future strategy. As the pharmaceutical landscape evolves, these spending patterns will be crucial in shaping the industry's future.
Merck & Co., Inc. or Dr. Reddy's Laboratories Limited: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Novartis AG and Dr. Reddy's Laboratories Limited
Analyzing R&D Budgets: Gilead Sciences, Inc. vs Vertex Pharmaceuticals Incorporated
Research and Development Investment: Gilead Sciences, Inc. vs Neurocrine Biosciences, Inc.
Comparing Innovation Spending: Gilead Sciences, Inc. and BeiGene, Ltd.
Comparing Innovation Spending: Gilead Sciences, Inc. and Regeneron Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Gilead Sciences, Inc. and Jazz Pharmaceuticals plc
Dr. Reddy's Laboratories Limited or ADMA Biologics, Inc.: Who Invests More in Innovation?
Dr. Reddy's Laboratories Limited vs HUTCHMED (China) Limited: Strategic Focus on R&D Spending
Dr. Reddy's Laboratories Limited or Iovance Biotherapeutics, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Dr. Reddy's Laboratories Limited and Ligand Pharmaceuticals Incorporated
Research and Development Expenses Breakdown: Dr. Reddy's Laboratories Limited vs Xencor, Inc.